Page last updated: 2024-10-27

fleroxacin and Acute Disease

fleroxacin has been researched along with Acute Disease in 10 studies

Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"The pharmacokinetics of fleroxacin, a new broad-spectrum fluoroquinolone, were measured by positron emission tomography (PET) with [18F]fleroxacin in five patients with acute bacterial exacerbations of chronic bronchitis and in five patients with symptomatic, complicated urinary tract infection."9.08Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography. ( Alpert, NM; Babich, JW; Bonab, A; Chodosh, S; Cleeland, R; Correia, JA; Fischman, AJ; Kamitsuka, P; Liu, YY; Livni, E; McGovern, F; Prosser, BL; Rubin, RH, 1996)
"The purpose of this work was to evaluate the efficacy and safety of a single dose of 400 mg of fleroxacin for the empiric antibiotic treatment of acute diarrhea in adult patients."9.08[Single dose of fleroxacin for the treatment of adult acute diarrhea]. ( Casero, R; Colazo, A; Gandini, B; Kitzmann, P; Lalik, S; Monterisi, A; Patrito, V; Pereyra de Santiago, O; Polo Friz, H; Rocchi, M; Rojo, S; Serra, J, 1997)
"The objective of this double-blind, multicenter study was to compare the efficacy and safety of oral fleroxacin, 400 mg once daily for 7 days, with amoxicillin, 500 mg administered every 8 hours for 7 days, in the treatment of acute exacerbation of chronic bronchitis."9.07Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis. ( Ulmer, W, 1993)
"In a multicenter study the efficacy and safety of oral fleroxacin at 400 mg once a day and amoxicillin at 500 mg three times daily for 7 days were compared for the treatment of patients with acute bacterial exacerbations of chronic bronchitis due to drug-susceptible bacteria."9.07Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis. ( Chodosh, S, 1993)
"Fleroxacin, administered intravenously at a dosage of 400 mg once a day, was compared with ceftazidime, 0."6.67Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections. ( Farkas, SA, 1993)
"The pharmacokinetics of fleroxacin, a new broad-spectrum fluoroquinolone, were measured by positron emission tomography (PET) with [18F]fleroxacin in five patients with acute bacterial exacerbations of chronic bronchitis and in five patients with symptomatic, complicated urinary tract infection."5.08Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography. ( Alpert, NM; Babich, JW; Bonab, A; Chodosh, S; Cleeland, R; Correia, JA; Fischman, AJ; Kamitsuka, P; Liu, YY; Livni, E; McGovern, F; Prosser, BL; Rubin, RH, 1996)
"The purpose of this work was to evaluate the efficacy and safety of a single dose of 400 mg of fleroxacin for the empiric antibiotic treatment of acute diarrhea in adult patients."5.08[Single dose of fleroxacin for the treatment of adult acute diarrhea]. ( Casero, R; Colazo, A; Gandini, B; Kitzmann, P; Lalik, S; Monterisi, A; Patrito, V; Pereyra de Santiago, O; Polo Friz, H; Rocchi, M; Rojo, S; Serra, J, 1997)
"The objective of this double-blind, multicenter study was to compare the efficacy and safety of oral fleroxacin, 400 mg once daily for 7 days, with amoxicillin, 500 mg administered every 8 hours for 7 days, in the treatment of acute exacerbation of chronic bronchitis."5.07Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis. ( Ulmer, W, 1993)
"In a multicenter study the efficacy and safety of oral fleroxacin at 400 mg once a day and amoxicillin at 500 mg three times daily for 7 days were compared for the treatment of patients with acute bacterial exacerbations of chronic bronchitis due to drug-susceptible bacteria."5.07Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis. ( Chodosh, S, 1993)
"The objective of this open label, non-comparative study was to evaluate the efficacy and safety of fleroxacin 400mg administered orally once daily to patients with acute osteomyelitis and/or acute septic arthritis."5.07Clinical evaluation of fleroxacin in the treatment of bone and joint infections. ( Chen, YS; Cheng, DL; de Garis, ST; Hsieh, TL; Lin, HH; Liu, CY; Liu, YC; Wang, RS; Yen, MY, 1992)
"Fleroxacin, administered intravenously at a dosage of 400 mg once a day, was compared with ceftazidime, 0."2.67Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections. ( Farkas, SA, 1993)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's7 (70.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ulmer, W1
Chodosh, S2
Farkas, SA1
Fischman, AJ1
Livni, E1
Babich, JW1
Alpert, NM1
Bonab, A1
McGovern, F1
Kamitsuka, P1
Liu, YY1
Cleeland, R1
Prosser, BL1
Correia, JA1
Rubin, RH1
Polo Friz, H1
Kitzmann, P1
Lalik, S1
Serra, J1
Rojo, S1
Rocchi, M1
Monterisi, A1
Colazo, A1
Casero, R1
Patrito, V1
Pereyra de Santiago, O1
Gandini, B1
Lassus, A1
Abath Filho, L1
Santos Júnior, MF1
Belli, L1
Liu, YC1
Cheng, DL1
Liu, CY1
de Garis, ST1
Lin, HH1
Hsieh, TL1
Yen, MY1
Wang, RS1
Chen, YS1
Møller, BR1
Kaspersen, P1
Mamsen, A1
Korsager, B1
Quitzau, K1
Kosmidis, J1
Gargalianos, P1
Adamis, G1
Petropoulou, D1
Makris, D1
Eugster, H1
Eichmann, A1

Trials

8 trials available for fleroxacin and Acute Disease

ArticleYear
Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis.
    The American journal of medicine, 1993, Mar-22, Volume: 94, Issue:3A

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Bacteria; Bronchitis; Chronic Disease; D

1993
Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis.
    The American journal of medicine, 1993, Mar-22, Volume: 94, Issue:3A

    Topics: Acute Disease; Aged; Amoxicillin; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Confi

1993
Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections.
    The American journal of medicine, 1993, Mar-22, Volume: 94, Issue:3A

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bacteria; Bronchitis; Ceftazidime; Female; Fleroxacin

1993
Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:3

    Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Fleroxacin; Fluorine

1996
[Single dose of fleroxacin for the treatment of adult acute diarrhea].
    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina), 1997, Volume: 55, Issue:1-2

    Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Diarrhea; Double-Blind Method; Female; Fleroxacin

1997
Comparison of fleroxacin and penicillin G plus probenecid in the treatment of acute uncomplicated gonococcal infections.
    Genitourinary medicine, 1992, Volume: 68, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Drug Therapy, Combination; Fleroxacin; Gonorrhea; Humans; Male; Mi

1992
Clinical evaluation of fleroxacin in the treatment of bone and joint infections.
    The Southeast Asian journal of tropical medicine and public health, 1992, Volume: 23, Issue:3

    Topics: Acute Disease; Adult; Aged; Arthritis, Infectious; Bacteremia; Female; Fleroxacin; Humans; Male; Mid

1992
Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D

    Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Ciproflo

1988

Other Studies

2 other studies available for fleroxacin and Acute Disease

ArticleYear
Fleroxacin in the treatment of uncomplicated acute cystitis in women.
    The Journal of antimicrobial chemotherapy, 1988, Volume: 22 Suppl D

    Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Cystitis; Female; Fleroxacin; Follow-Up

1988
Single dose therapy with Ro 23-6240 in patients suffering from acute, non-complicated gonococcal infection.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Gonorrhea; Humans; Male

1987